- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2018
- Public Summary Document (PSD) November 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2018 PBAC Meeting - Word
Alemtuzumab – November 2018
Alemtuzumab: Solution concentrate for I.V. infusion 12 mg in 1.2 mL; Lemtrada®
Last updated
15 March 2019